No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Companies Like Dianthus Therapeutics (NASDAQ:DNTH) Are In A Position To Invest In Growth
H.C. Wainwright Starts Dianthus as Buy, Cites Lead Drug Candidate
Analysts' Opinions Are Mixed on These Healthcare Stocks: 60 Degrees Pharmaceuticals, Inc. (SXTP), GoodRx Holdings (GDRX) and Dianthus Therapeutics (DNTH)
Dianthus Therapeutics' DNTH103: A Potential Game-Changer in Autoimmune Disease Treatment
Express News | Dianthus Therapeutics, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating and Target Price $40
Dianthus Therapeutics (DNTH) Gets a Buy From Wedbush
No Data
I-am-ToTh :
BuyHighSellLow88 : Are you looking for someone to buy your shares or why are you posting this here?
AGeezy : where did you find this news?
Jaguar8 : Current short shares available now is approximately 16M shares
nilos Wayne BuyHighSellLow88: yes
View more comments...